BRIEF—Karolinska Development appoints Fredrik Järrsten as deputy CEO

Sweden’s life sciences investment company Karolinska Development (STO: KDEV) has appointed Fredrik Järrsten as deputy chief executive, adding to his role as chief financial officer since joining the company in 2017.

Mr Järrsten has more than 25 years of experience within investments and business development, including 13 years in the Life Science sector.

“The appointment of Fredrik Järrsten as deputy CEO is a consequence of his deep engagement and significant contributions to the leadership of Karolinska Development. Alongside his continuous responsibilities as CFO, Fredrik will now be able to focus even more on strategic development and related areas,” says Viktor Drvota, CEO of Karolinska Development.